Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
Immunology: A tolerant approach.
The use of aminopyridines in neurological disorders.
Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Prevalence of stress urinary incontinence in women with multiple sclerosis.
Serum level of interleukin-6 in Chinese patients with multiple sclerosis.
Dimethyl fumarate (Tecfidera) for multiple sclerosis.
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
The next generation of exoskeletons: lighter, cheaper devices are in the works.
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Placebo power.
Segway use in individuals with multiple sclerosis.
B-57The Temporal Onset of Cognitive Fatigue in Multiple Sclerosis.
A cross-sectional study examining multiple mobility device use and fall status among middle-aged and older adults with multiple sclerosis.
Brain Region-specific Alterations in the Gene Expression of Cytokines, Immune Cell Markers and Cholinergic System Components During Peripheral Endotoxin-induced Inflammation.
Multiple sclerosis: summary of NICE guidance.
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Immune modulating peptides for the treatment and suppression of multiple sclerosis.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Relapses in patients treated with fingolimod after previous exposure to natalizumab.
Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus.
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
Removing confounding factors via constraint-based clustering: An application to finding homogeneous groups of multiple sclerosis patients.
A touch of MS: Therapeutic mislabeling.

Pages